>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:
  • KOOL +9.1%, CPRT +4.5%
Other news:
  • WAC +61.5% (entered into a commitment letter with Barclays who has agreed to increase financing available)
  • ALNY +20.7% (Alnylam Pharma and Sanofi (SNY) announce that the APOLLO Phase 3 study of patisiran met its primary efficacy endpoint and all secondary endpoints)
  • GEMP +15% (plans to advance its product candidate gemcabene into Phase 3 development in 2018 and is preparing for end of Phase 2 meeting w/ the FDA and EMA in early 2018 )
  • HTGM +14.7% (USPTO has issued two U.S. Patents covering HTG's technology and applications of its technology)
  • KPTI +13.1% (reports 'a successful outcome from the Phase 2 portion of the SEAL study)
  • IBIO +9.1% (provides update on recent patents; received patent entitled 'system for expression of genes in plants')
  • MBII +4.6% (ÉLÉPHANT VERT will develop and market two of MBI's products in Morocco, Tunisia and Algeria )
  • AVEO +3.9% (announces that EUSA Pharma has opted into the Phase 1/2 TiNivo study, triggers $2 mln R&D payment to AVEO)
  • MZOR +2.7% (receives CE Mark in EU approval for its Mazor X Surgical Assurance Platform)
  • AUPH +1.6% (will host an R&D Day on October 20 at 8:00am ET)
  • S +1.5% (continued strength)
  • STON +1.4% (obtained New York Stock Exchange listing extension and 2016 10-K is now available)
  • CX +1.3% ( offers to purchase for cash any and all of CEMEX Finance LLC's outstanding 9.375% Senior Secured Notes due 2022)
  • RESI +1.1% (provides update on impact of Hurricane Irma; inspections so far indicate limited damage relative to co's overall portfolio )
Analyst comments:
  • CBAY +5.4% (initiated with a Overweight at Cantor Fitzgerald)
  • EVH +1.3% (initiated with a Overweight at KeyBanc Capital Mkts)
  • AAL +1.1% (upgraded to Outperform from Mkt Perform at Raymond James)
  • ATVI +1.1% (initiated with a Buy at Buckingham Research)
  • EA +1% (initiated with a Buy at Buckingham Research)
  • PFE +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley)